Author + information
- Received March 30, 2013
- Revision received July 25, 2013
- Accepted August 1, 2013
- Published online November 1, 2013.
- Mackram F. Eleid, MD,
- Charanjit S. Rihal, MD, MBA,
- Rajiv Gulati, MD, PhD and
- Malcolm R. Bell, MBBS∗ ()
- ↵∗Reprint requests and correspondence:
Dr. Malcolm R. Bell, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905.
A growing body of evidence now supports the use of transradial percutaneous intervention (TRI) as the preferred access site for the treatment of patients with ST-segment elevation myocardial infarction (STEMI). Historically, TRI has been avoided in the STEMI population due to concerns over longer procedure time, longer door-to-device time, higher crossover rates, and the experience level required with TRI compared with transfemoral access. However, in recent years, recognition of the impact of periprocedural bleeding on mortality in patients with acute coronary syndromes has garnered interest in the utility of TRI as an established method to reduce bleeding. Registry data, meta-analyses, and randomized control trials all similarly demonstrate that TRI is associated with reduced periprocedural bleeding and lower mortality compared with transfemoral access in the STEMI population. Additional benefits of TRI include enhanced patient comfort, reduced hospital length of stay, and reduced cost. Despite the evidence, trends in use of TRI in the United States have shown a slow adoption rate as a result of multiple barriers in clinical practice and doubts about the mechanism and causal relationship of mortality reduction with TRI. We summarize the current evidence and propose a call to action to foster training of TRI in cardiovascular fellowship programs and post-fellowship courses, and for more widespread implementation of TRI in STEMI patients.
The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Received March 30, 2013.
- Revision received July 25, 2013.
- Accepted August 1, 2013.
- American College of Cardiology Foundation